InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

EXELIXIS, INC.

EXEL Clue Score84
United States Fiscal year ends January CIK 0000939767 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Mary C Beckerle
10 Aug 2026
Director
Sold on a plan
9,812
$53.66
$526.51K
Sue Gail Eckhardt
1 Jun 2026
Director
Sold on a plan
9,812
$50.14
$491.97K
Jack L Wyszomierski
1 Jun 2026
Director
Sold on a plan
3,925
$50.55
$198.41K
Brenda Hefti
18 May 2026
SVP and General Counsel
Sold on a plan
6,625
$50.21
$332.64K
Brenda Hefti
18 Feb 2026
SVP and General Counsel
Sold on a plan
18,669
$44.01
$821.62K
Sue Gail Eckhardt
13 Feb 2026
Director
Sold on a plan
3,856
$43.79
$168.85K
Jack L Wyszomierski
3 Jun 2025
Director
Sold on a plan
7,535
$43.09
$324.68K
Sue Gail Eckhardt
2 Jun 2025
Director
Sold on a plan
4
$43.67
$174.68
Sue Gail Eckhardt
2 Jun 2025
Director
Sold on a plan
18,834
$42.74
$804.97K
Patrick J. Haley
14 May 2025
EVP, Commercial
Sold on a plan
10,000
$42.68
$426.80K
Dana Aftab
1 May 2025
CSO/EVP Disc & Trans Research
Sold on a plan
1,508
$39.00
$58.81K
Patrick J. Haley
3 Mar 2025
EVP, Commercial
Sold on a plan
10,000
$38.80
$388.00K
Patrick J. Haley
22 Nov 2024
EVP, Commercial
Sold on a plan
10,000
$35.27
$352.70K
Patrick J. Haley
18 Nov 2024
EVP, Commercial
Sold on a plan
19,381
$34.41
$666.90K
Patrick J. Haley
18 Nov 2024
EVP, Commercial
Sold on a plan
22,207
$34.31
$761.92K
Jeffrey Hessekiel
1 Nov 2024
EVP & General Counsel
Sold on a plan
50,000
$34.13
$1.71M
Dana Aftab
30 Oct 2024
CSO/EVP Disc & Trans Research
Sold on a plan
1,162
$31.40
$36.49K
Jeffrey Hessekiel
28 Oct 2024
EVP & General Counsel
Sold on a plan
25,000
$28.39
$709.75K
Jeffrey Hessekiel
23 Sep 2024
EVP & General Counsel
Sold on a plan
25,000
$26.38
$659.50K
Patrick J. Haley
7 Aug 2024
EVP, Commercial
Sold on a plan
14,000
$25.50
$357.00K
Jack L Wyszomierski
4 Jun 2024
Director
Sold on a plan
8,287
$22.00
$182.31K
Jeffrey Hessekiel
13 Dec 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$23.01
$575.25K
Patrick J. Haley
12 Dec 2023
EVP, Commercial
Sold on a plan
14,149
$22.50
$318.35K
Jeffrey Hessekiel
4 Dec 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$22.06
$551.50K
Jeffrey Hessekiel
30 Nov 2023
EVP, General Counsel & Sec
Sold on a plan
25,000
$22.01
$550.25K
Dana Aftab
30 Aug 2023
CSO/EVP Disc & Trans Research
Sold on a plan
4,600
$22.47
$103.36K
Showing 250 of 499 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 706
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 283
Sales at will 131
Transactions with no price 0
Shares from compensation/vesting 41,557,913
Sales filed before the plan box existed 101
History held since 6 Oct 2006